--- title: Buy Myrbetriq (Mirabegron) 50mg Pills Online description: Myrbetriq (Mirabegron) 50mg pills from Astellas treat overactive bladder symptoms like urgency and incontinence. Order from our trusted online pharmacy for verified quality and prompt delivery. type: product language: en url: https://liabilis.com/order-myrbetriq-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 119.99 price_max: 421.99 currency: USD offers: - name: 50mg x 30 pills price: 119.99 - name: 50mg x 60 pills price: 230.99 - name: 50mg x 90 pills price: 336.99 - name: 50mg x 120 pills price: 421.99 --- # Buy Myrbetriq (Mirabegron) 50mg Pills Online Myrbetriq, containing Mirabegron and developed by Astellas, is a beta-3 adrenergic agonist used to treat overactive bladder in adults, reducing symptoms such as urgency, frequency, and incontinence. It provides relief for those affected by this condition. Available in 50mg pills through our secure online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **50mg** | 30 pills | **$119.99** | $4.00 | In Stock | | **50mg** | 60 pills | **$230.99** | $3.85 | In Stock | | **50mg** | 90 pills | **$336.99** | $3.74 | In Stock | | **50mg** | 120 pills | **$421.99** | $3.52 | In Stock | [Buy Now](https://liabilis.com/order-myrbetriq-online-en.html) ## Introduction Myrbetriq is a prescription medication indicated for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge urinary incontinence. The active ingredient is mirabegron, a selective β3-adrenergic receptor agonist that relaxes the detrusor muscle during the storage phase of the urinary cycle. It is supplied as a 50 mg oral pill and belongs to the class of β3-agonist agents. In addition to OAB, mirabegron is sometimes employed off-label for neurogenic detrusor overactivity, although such use must be overseen by a qualified clinician. ## Quick Reference Facts **Active Ingredient** : mirabegron **Form** : pill 50 mg **Primary and Off-Label Uses** : • Overactive bladder (OAB) - urgency, frequency, urge incontinence : • Neurogenic detrusor overactivity (off-label) ## What is Myrbetriq? Myrbetriq is the generic version of medications that contain the active compound mirabegron. Mirabegron was first approved by the U.S. Food and Drug Administration (FDA) in 2012 for OAB and is marketed under brand names such as Myrbetriq and Betmiga. The medication is formulated as a film-coated oral tablet for once-daily administration. While the brand name Myrbetriq remains widely recognized, the generic formulation offers the same therapeutic effect at a lower cost, meeting bioequivalence standards established by regulatory agencies. The development of mirabegron was led by Astellas Pharma, and subsequent generic manufacturers have obtained approval after demonstrating comparable pharmacokinetic profiles. ## How Myrbetriq Works Mirabegron activates β3-adrenergic receptors located on the smooth muscle of the urinary bladder. Stimulation of these receptors triggers a cascade that increases cyclic adenosine monophosphate (cAMP) levels, leading to relaxation of the detrusor muscle during the filling phase. This relaxation reduces involuntary contractions that cause urgency and leakage, allowing the bladder to store a greater volume of urine without triggering the urge to void. The drug has a rapid onset of action, with clinical benefit often observed within the first week of therapy, and a half-life of approximately 50 hours, supporting once-daily dosing. Mirabegron is primarily metabolized by the liver via CYP3A4 and CYP2D6 pathways and is excreted unchanged in the urine and feces. ## Conditions Treated with Myrbetriq - **Overactive bladder (OAB)** - Mirabegron improves bladder capacity and decreases the frequency of urgency episodes by relaxing the detrusor muscle, addressing the core pathophysiology of OAB. - **Urgency urinary incontinence** - By reducing involuntary detrusor contractions, the medication lessens the episodes of leakage associated with sudden urges. - **Frequency of urination** - Patients experience fewer daytime voids because the bladder can hold more urine before the urge signal is generated. ## Is Myrbetriq the Right Medication for You? Myrbetriq is appropriate for adults who have been diagnosed with OAB and who have not achieved satisfactory control with behavioral therapies alone. It is particularly useful when antimuscarinic agents cause intolerable side effects such as dry mouth or constipation. Suitable candidates include individuals with normal or mildly elevated blood pressure, as mirabegron can cause modest increases in systolic pressure. Contraindications include uncontrolled hypertension (≥180/110 mm Hg), severe hepatic impairment (Child-Pugh Class C), and known hypersensitivity to mirabegron or any tablet excipients. Caution is advised in patients with moderate renal impairment, in the elderly, and in those taking other agents that affect the CYP2D6 pathway, as drug-drug interactions may alter plasma concentrations. ## Buying Myrbetriq from [our online pharmacy](https://liabilis.com/order-myrbetriq-online-en.html) ### Why Choose Our Service? Access to affordable, high-quality medications can be challenging through conventional channels. Our platform bridges that gap by offering Myrbetriq at prices close to manufacturer cost, helping patients manage their health without financial strain. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every shipment is sourced from vetted suppliers that comply with recognized regulatory frameworks, such as the European Medicines Agency or the U.S. FDA. ### Pricing & Access Because Myrbetriq is a generic formulation, it is offered at a fraction of the price of branded equivalents. This cost advantage makes long-term OAB management more sustainable, especially for patients without insurance coverage for specialty drugs. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express courier typically within 7 days, or standard airmail in approximately 3 weeks. Privacy is maintained throughout the fulfillment process, giving you confidence that your medication arrives safely and confidentially. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - The usual adult dose is one 50 mg tablet taken orally once daily, with or without food. - **Missed dose** - If you forget a dose, take it as soon as you remember on the same day. Skip the missed dose if it is near the time of the next scheduled dose; do not double-dose. - **Overdose** - Signs may include rapid heart rate, elevated blood pressure, or severe headache. Seek emergency medical attention immediately; treatment is supportive and symptomatic. **Practical precautions** - Avoid taking mirabegron with strong CYP2D6 inhibitors (e.g., fluoxetine) unless dose adjustment is advised. - Alcohol does not directly interact with mirabegron, but excessive consumption may exacerbate dizziness. - Do not operate heavy machinery or drive until you know how the medication affects you, especially during the first few days of therapy. ## Safety Information ### ⚠️ Who Should Not Take Myrbetriq - Patients with uncontrolled hypertension (≥180/110 mm Hg) - Individuals with severe hepatic impairment (Child-Pugh C) - Known hypersensitivity to mirabegron or tablet ingredients ### Common Side Effects - **Hypertension** - Mild to moderate increases in blood pressure; monitor routinely. - **Nasopharyngitis** - Common cold-like symptoms; usually self-limited. - **Urinary retention** - May occur in patients with pre-existing bladder outlet obstruction; assess urinary flow if symptoms arise. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe hypertension** - Sustained systolic pressure >180 mm Hg or diastolic >110 mm Hg. - **Angio-edema** - Swelling of lips, tongue, or throat requiring urgent care. - **Life-threatening arrhythmias** - Palpitations accompanied by fainting or chest pain. ### Drug & Food Interactions - **CYP2D6 inhibitors** (e.g., quinidine, paroxetine) - May increase mirabegron plasma levels; dose reduction may be necessary. - **CYP3A4 inducers** (e.g., rifampin) - Can reduce drug exposure, potentially diminishing efficacy. - **Diuretics** - May heighten the risk of urinary retention; monitor fluid balance. ## Off-Label and Investigational Uses of Myrbetriq Mirabegron has been investigated for neurogenic detrusor overactivity in patients with spinal cord injury or multiple sclerosis. Small clinical studies suggest modest improvement in bladder storage capacity, but regulators have not approved this indication. Occasionally, clinicians use mirabegron to manage chronic urinary urgency in patients who cannot tolerate antimuscarinic agents, though such practice should occur under specialist supervision. Research is ongoing to explore its role in combination therapy with antimuscarinics for refractory OAB. ## Storage & Handling - Store tablets at 20 °C-25 °C (68 °F-77 °F). - Protect from excess heat, moisture, and direct sunlight. - Keep the container tightly closed and out of reach of children. - Do not use tablets beyond the printed expiration date; discard unused medication according to local pharmacy guidelines. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I take Myrbetriq while traveling across time zones?** Yes. Because the medication is taken once daily, maintain a consistent 24-hour interval regardless of local time changes. If you cross the International Date Line, simply continue the established dosing schedule. - **Is it safe to consume caffeine while on Myrbetriq?** Moderate caffeine intake does not directly interact with mirabegron, but high amounts may increase urinary frequency, potentially counteracting therapeutic benefits. **Product & Formulation Details** - **What do Myrbetriq tablets look like?** The generic tablet is a white, film-coated round pill, imprinted with “50 MG” on one side. Appearance may vary slightly between manufacturers, but the imprint and dosage remain consistent. - **Can the tablet be split or crushed?** Splitting is acceptable if a lower dose is required and the tablet has a score line; however, crushing is not recommended because it may affect the drug’s release profile. **Regulatory & Safety Nuances** - **Will Myrbetriq show up on a standard drug test?** Mirabegron is not typically screened for in routine occupational drug panels, as it is not a controlled substance. - **Is Myrbetriq safe for pregnant or breastfeeding women?** Animal studies have not demonstrated fetal risk, but human data are limited. The medication should be used during pregnancy only if the potential benefit outweighs the potential risk, and breastfeeding is not recommended without medical advice. **Scientific & Clinical Curiosity** - **What was the pivotal trial that led to Myrbetriq’s approval?** The Phase III SCORPIO trial demonstrated significant reductions in urgency episodes compared with placebo, supporting regulatory approval for OAB. - **How does mirabegron compare to antimuscarinic drugs?** Mirabegron provides comparable efficacy in reducing OAB symptoms but has a lower incidence of anticholinergic side effects such as dry mouth and constipation, making it an alternative for patients intolerant to antimuscarinics. ## Glossary **β3-Adrenergic Receptor** : A protein on bladder smooth-muscle cells that, when activated, causes muscle relaxation and increased bladder capacity. **Bioequivalence** : The condition wherein a generic product demonstrates the same rate and extent of absorption as the brand-name reference drug. **CYP2D6** : An enzyme in the liver that metabolizes many medications; inhibitors can raise drug levels of substrates like mirabegron. **Detrusor Muscle** : The muscle layer of the bladder wall responsible for contracting to expel urine; overactivity leads to OAB symptoms. **Pharmacokinetics** : The study of how a drug is absorbed, distributed, metabolized, and excreted by the body. ## Disclaimer The information presented about Myrbetriq is intended for general educational purposes and does not replace personalized medical advice. Treatment decisions, including any off-label applications, should be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-myrbetriq-online-en.html) provides access to Myrbetriq for individuals who may encounter limited availability through conventional pharmacies, insurance-based prescription programs, or who seek cost-effective generic alternatives. Always discuss any changes to your medication regimen with your physician before initiating, modifying, or discontinuing therapy.